Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001-2023)

被引:9
作者
Zhu, Xiaofei [1 ]
Zhou, Ziyuan [2 ]
Pan, Xiaxia [3 ]
机构
[1] Hangzhou Ninth Peoples Hosp, Dept Infect Dis, Hangzhou, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Sch Med, State Key Lab Diag & Treatment Infect Dis,Natl Cli, Hangzhou, Peoples R China
[3] Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Canc Ctr,Dept Pulm & Crit Care Med, Hangzhou, Peoples R China
关键词
liver cirrhosis; gut microbiota; bibliometrics; VOSviewers; CiteSpace; HELICOBACTER-PYLORI INFECTION; BACTERIAL TRANSLOCATION; HEPATIC-ENCEPHALOPATHY; INTESTINAL MICROBIOME; OXIDATIVE STRESS; OBETICHOLIC ACID; BILE-ACIDS; PROGRESSION; DISEASE; RIFAXIMIN;
D O I
10.3389/fmicb.2024.1342356
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction The gut-liver axis has emerged as a focal point in chronic liver disorders, prompting more research into the role of the gut microbiota in liver cirrhosis. In individuals with liver cirrhosis, changes in the structure and function of the gut microbiota are closely tied to clinical prognosis. However, there is a scarcity of bibliometric evaluations conducted in this particular field. Methods This study is aiming to conduct a complete analysis of the knowledge structure and centers pertaining to gut microbiota in liver cirrhosis using bibliometric methods. Publications on gut microbiota and liver cirrhosis from 2001 to 2023 are sourced from the Web of Science Core Collection. For the bibliometric analysis, we employ VOSviewer, CiteSpace, and the R package "bibliometrix". Results Our study encompasses a comprehensive collection of 3109 articles originating from 96 countries, with notable contributions from leading nations such as the United States and China. The quantity of publications concerning the gut microbiota of liver cirrhosis rises annually. The University of California San Diego, Virginia Commonwealth University, Zhejiang University are the primary research institutions. World Journal of Gastroenterology publishes the most papers in this field, while hepatology is the most frequently co-cited journal. These publications come from a total of 15,965 authors, and the most prolific authors are Bajaj Jasmohan S., Schnabl Bernd and Gillevet Patrick M., while the most co-cited authors are Bajaj Jasmohan S., Younossi Zobair M., and Reiner Wiest. In addition, "dysbiosis", "gut microbiota", "intestinal barrier", "fecal microbiota transplantation", and "complement-system" are the primary keywords of research trends in recent years. Discussion This study offering a comprehensive insight into the research dynamics surrounding gut microbiota in patients with liver cirrhosis. It delineates the current research frontiers and hotspots, serving as a valuable guide for scholars.
引用
收藏
页数:21
相关论文
共 140 条
[1]   The gut-liver axis in liver disease: Pathophysiological basis for therapy [J].
Albillos, Agustin ;
de Gottardi, Andrea ;
Rescigno, Maria .
JOURNAL OF HEPATOLOGY, 2020, 72 (03) :558-577
[2]   Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg [J].
Arab, Juan P. ;
Martin-Mateos, Rosa M. ;
Shah, Vijay H. .
HEPATOLOGY INTERNATIONAL, 2018, 12 :S24-S33
[3]   bibliometrix: An R-tool for comprehensive science mapping analysis [J].
Aria, Massimo ;
Cuccurullo, Corrado .
JOURNAL OF INFORMETRICS, 2017, 11 (04) :959-975
[4]   Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders [J].
Aron-Wisnewsky, Judith ;
Vigliotti, Chloe ;
Witjes, Julia ;
Le, Phuong ;
Holleboom, Adriaan G. ;
Verheij, Joanne ;
Nieuwdorp, Max ;
Clement, Karine .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (05) :279-297
[5]   Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis [J].
Arvaniti, Vasiliki ;
D'Amico, Gennaro ;
Fede, Giuseppe ;
Manousou, Pinelopi ;
Tsochatzis, Emmanuel ;
Pleguezuelo, Maria ;
Burroughs, Andrew Kenneth .
GASTROENTEROLOGY, 2010, 139 (04) :1246-+
[6]   Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC [J].
Awoniyi, Muyiwa ;
Wang, Jeremy ;
Ngo, Billy ;
Meadows, Vik ;
Tam, Jason ;
Viswanathan, Amba ;
Lai, Yunjia ;
Montgomery, Stephanie ;
Farmer, Morgan ;
Kummen, Martin ;
Thingholm, Louise ;
Schramm, Christoph ;
Bang, Corinna ;
Franke, Andre ;
Lu, Kun ;
Zhou, Huiping ;
Bajaj, Jasmohan S. ;
Hylemon, Phillip B. ;
Ting, Jenny ;
Popov, Yury, V ;
Hov, Johannes Roksund ;
Francis, Heather L. ;
Sartor, Ryan Balfour .
GUT, 2023, 72 (04) :671-685
[7]   Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites [J].
Bai, Xiaowu ;
Wei, Hong ;
Liu, Weixin ;
Coker, Olabisi Oluwabukola ;
Gou, Hongyan ;
Liu, Changan ;
Zhao, Liuyang ;
Li, Chuangen ;
Zhou, Yunfei ;
Wang, Guoping ;
Kang, Wei ;
Ng, Enders Kwok-wai ;
Yu, Jun .
GUT, 2022, 71 (12) :2439-2450
[8]   Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis [J].
Bajaj, J. S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 :11-26
[9]   Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis [J].
Bajaj, J. S. ;
Heuman, D. M. ;
Hylemon, P. B. ;
Sanyal, A. J. ;
Puri, P. ;
Sterling, R. K. ;
Luketic, V. ;
Stravitz, R. T. ;
Siddiqui, M. S. ;
Fuchs, M. ;
Thacker, L. R. ;
Wade, J. B. ;
Daita, K. ;
Sistrun, S. ;
White, M. B. ;
Noble, N. A. ;
Thorpe, C. ;
Kakiyama, G. ;
Pandak, W. M. ;
Sikaroodi, M. ;
Gillevet, P. M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) :1113-1125
[10]   Promises of microbiome-based therapies [J].
Bajaj, Jasmohan S. ;
Ng, Siew C. ;
Schnabl, Bernd .
JOURNAL OF HEPATOLOGY, 2022, 76 (06) :1379-1391